REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 68 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Lessors of Other Real Estate Property | Advertising Agencies | Office Administrative Services
Full name: Dr.Max 68 S.R.O. Profile Updated: July 25, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 68 S.R.O. is a company based in Slovakia, with its head office in Kosice. It operates in the Pharmacies and Drug Stores industry. It was first established on June 24, 2014. It currently has a total number of 5 - 9 (2025) employees. There was a net sales revenue increase of 40.72% reported in Dr.Max 68 S.R.O.’s latest financial highlights for 2024. Over the same period, its total assets grew by 25%. The net profit margin of Dr.Max 68 S.R.O. increased by 0.49% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 68 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 68 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 68 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 68 S.R.O. report to view the information.
Incorporation Date:
June 24, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 68 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
40.72%
Total operating revenue
40.62%
Operating profit (EBIT)
83.72%
EBITDA
44.91%
Net Profit (Loss) for the Period
85.68%
Total assets
25%
Total equity
24.87%
Operating Profit Margin (ROS)
0.54%
Net Profit Margin
0.49%
Return on Equity (ROE)
6.52%
Debt to Equity Ratio
-0.72%
Quick Ratio
0.02%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?